BioLeaders Donates Immune-Boosting Products to Daegu and Gyeongbuk Medical Staff... "Joining Crisis Overcome"

[Asia Economy Reporter Hyunseok Yoo] BioLeaders announced on the 4th that it donated PGA soft capsules worth 30 million KRW to medical staff in the Daegu and Gyeongbuk regions who are struggling due to the spread of COVID-19.

PGA soft capsules are health functional foods made based on the new drug candidate substance 'poly-gamma-glutamic acid' being developed as a cancer treatment. Clinical trial results showed that oral administration of poly-gamma-glutamic acid increased NK cells (natural killer cells), immune cells in the body, by more than 52.3%, demonstrating an immune-enhancing effect.

NK cells are a type of white blood cell responsible for innate immunity that accurately identify and eliminate virus-infected cells or cancer cells generated in the body. They are major immune cells that strengthen the body's immune system by secreting perforin to create holes in enemy cells or by releasing cytokines to recruit other immune cells.

BioLeaders has also proven the inhibitory function of poly-gamma-glutamic acid against SARS coronavirus through joint research with Hanyang University College of Pharmacy. In non-clinical efficacy evaluations targeting human respiratory viruses such as pandemic influenza virus, infection suppression activity was also confirmed.

A company official stated, “We hope that the donation of PGA soft capsules will help maintain the health of medical staff involved in COVID-19 even a little,” and “We send thanks and support to everyone working hard to prevent the spread of the situation.” He added, “We plan to additionally seek ways to overcome this crisis.”

This content was produced with the assistance of AI translation services.